Financial Performance - Q3 2025 - Gross revenue reached $63 million, a 124% increase year-over-year compared to $2814 million in Q3 2024[21, 72] - Adjusted Net Income was $236 million, up from $147 million in the prior-year period[21, 72] - Adjusted EBITDA increased to $379 million, compared to $167 million in the prior-year period[21, 72] - Capital deployed for policy purchases totaled $1024 million[21] - Assets Under Management (AUM) reached $33 billion[16, 21] Growth & Profitability - Year-over-year revenue growth was 124%[22] - Year-over-year growth in capital deployed was 10%[22] - Adjusted Annualized Return on Equity (ROE) was 22%[22] - Adjusted Annualized Return on Invested Capital (ROIC) was 21%[20, 22] - Adjusted EBITDA Margin was 60%[20, 22] Revenue Mix & Targets - Life Solutions contributed 84% of revenue year-to-date, with a 5-year target of 30%[24] - Asset Group contributed 15% of revenue year-to-date, with a 5-year target of 30%[20, 24] - Technology contributed less than 1% of revenue year-to-date, with a 5-year target of 10%[24] - Wealth Advisors had no revenue year-to-date, with a 5-year target of 30%[24] Abacus Asset Group - Capital inflows for the quarter were $713 million, bringing the year-to-date total to $3544 million[25, 50] - Management fees for the quarter were $86 million, with a year-to-date total of $219 million[25, 50] - The company is targeting over $4 billion in fee-paying AUM by the end of 2026[25] ABL Tech - ABL Tech is tracking over 26 million lives[25, 62] - ABL Tech experienced a 21x year-over-year increase in lives tracked[25, 60]

Financial Performance - Q2 2025 - Total revenue nearly doubled, reaching $56.2 million compared to $29.1 million in the prior-year period, representing a 93% increase[54] - Adjusted Net Income increased to $21.9 million, compared to $11.7 million, and Adjusted EBITDA increased to $31.5 million, compared to $16.7 million in the prior-year period[54] - GAAP Net Income attributable to shareholders was $17.6 million, compared to $0.7 million in the prior-year period[54] - Assets Under Management (AUM) reached $3.3 billion[17,56] Growth & Capital Deployment - Capital deployed for policy purchases in Q2 2025 amounted to $121.8 million[31,56] - Longevity Funds attracted $123.1 million in capital inflows for the quarter, with the ETFs seeing a +9% increase in growth in AUM compared to the prior quarter[54] - Year-over-year growth in capital deployed totaled $142 million, representing a 16% increase[19] ABL Tech - Mortality Tracking - ABL Tech's mortality tracking system now covers 2,033,198 lives in Q2 2025[46] - ABL Tech experienced a 17x year-over-year increase in lives tracked[44] FY 2025 Guidance - The company raised its Adjusted Net Income guidance for FY 2025 to a range of $74 million to $80 million, implying a +59% to +72% year-over-year change[58]